EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Sociodemographic and Clinical Factors Impact Non‐Live Vaccine Coverage After Pediatric Solid Organ Transplantation: A Single Center Study

Adam Z. Blatt, Yunfei Wang, Yeh‐Chung Chang, Sarah M. Heston

Pediatric Transplantation · 2026-03 · 30 (3)

DOI: 10.1111/petr.70302 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Background Pediatric solid organ transplant (SOT) recipients are at increased risk of vaccine preventable diseases (VPD) due to both under‐vaccination and ineffective responses to vaccines while immunosuppressed. Current guidelines recommend timely post‐transplant immunization with non‐live vaccines and surveillance of vaccine‐specific titers to assess vaccine responses; however, institutional adherence to these recommendations may be variable. Methods This single‐center retrospective study of 199 pediatric SOT recipients (59 heart, 10 intestinal/multi‐visceral, 34 kidney, and 96 liver) evaluated guideline adherence to post‐vaccine serologic monitoring and identified sociodemographic and clinical factors associated with delayed and incomplete schedules for routine childhood non‐live vaccines after transplant. Results Serologic monitoring was utilized after only 8% of recommended vaccines, while participants' age at transplant (odds ratio [OR], 95% confidence interval [CI]: 0.86, 0.81–0.91), receipt of a heart transplant (OR, 95% CI: 0.32, 0.17–0.60), and coverage with private insurance (OR, 95% CI: 0.46, 0.25–0.85) were factors negatively associated with timely initiation or completion of non‐live vaccines after transplant. Conclusions The associations between age at transplant, heart transplantation, and type of insurance with under‐immunization warrant further investigation to address modifiable gaps in vaccine coverage and ensure pediatric SOT recipients are optimally protected from VPD.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →